Gareth Morgan, MD, PhD, FRCP, FRCPath, NYU Langone, New York, NY. This interview took place at the 19th International Myeloma Society Meeting (IMS) held in Los Angeles, CA, discusses mutational and copy number signatures in multiple myeloma, discussing the impact of these signatures on prognosis and response to therapy.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.